Physician profile
Steven Duffy
NPI 1154586188
$7,494.67
in general payments reported to CMS, 2019-2025
14 companies · $85.56 in 2025
The $85.56 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,484 · 2021: $4,004 · 2022: $1,649 · 2023: $215 · 2024: $57.77 · 2025: $85.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.96 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $6,662.94 | 2020-2022 | |
| Janssen Biotech, INC. | $311.95 | 2021-2023 | Darzalex |
| Bayer Healthcare Pharmaceuticals INC. | $122.98 | 2022 | |
| Cardinal Health 110 LLC | $119.21 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $88.64 | 2023 | |
| Novocure INC. | $65.56 | 2025 | Optune Gio |
| Genmab U.S., INC. | $34.02 | 2024 | |
| Welch Allyn | $33.70 | 2020 | |
| Tempus Ai, INC | $23.75 | 2024 | |
| Aveo Pharmaceuticals, INC. | $20.00 | 2025 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Duffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.